Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
<p>Abstract</p> <p>Background</p> <p>Inflammation plays a critical role in lung disease development and progression in cystic fibrosis. Azithromycin is used for the treatment of cystic fibrosis lung disease, although its mechanisms of action are poorly understood. We te...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-10-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/7/1/134 |